Literature DB >> 34550545

Progressive multifocal leukoencephalopathy with mild clinical conditions and detection of archetype-like JC virus in cerebrospinal fluid.

Kosuke Iwami1, Kazuo Nakamichi2, Masaaki Matsushima3, Azusa Nagai1, Shinichi Shirai1, Sho Nakakubo4, Ikuko Takahashi-Iwata1, Masafumi Yamada5, Ichiro Yabe1.   

Abstract

Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease of the central nervous system with a poor prognosis and is primarily caused by JC virus (JCV) with a mutation called prototype. We encountered a case of PML with moderate progression and analyzed the mutational patterns of JCV in the cerebrospinal fluid (CSF). A 19-year-old Japanese woman with mild neurological symptoms was diagnosed with combined immunodeficiency following pneumocystis pneumonia. Brain magnetic resonance imaging scan showed multiple brain lesions, and real-time polymerase chain reaction testing detected JCV in the CSF, leading to the diagnosis of PML. The disease course of PML was stable after administration of mefloquine and mirtazapine with immunoglobulin replacement therapy. In the JCV genome cloned from the patient CSF, DNA sequences of the gene encoding the capsid protein (VP1) and the non-coding control region exhibited small mutations. However, they were quite similar to those of the archetype JCV, which persists asymptomatically in healthy individuals. These findings provide insight into the mutational characteristics of JCV in PML with mild symptoms and progression.
© 2021. Journal of NeuroVirology, Inc.

Entities:  

Keywords:  Combined immunodeficiency; JC virus; Non-coding control region; Progressive multifocal leukoencephalopathy; VP1 gene

Mesh:

Substances:

Year:  2021        PMID: 34550545     DOI: 10.1007/s13365-021-01017-4

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  15 in total

1.  JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy.

Authors:  L A Pfister; N L Letvin; I J Koralnik
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Sequential changes in the non-coding control region sequences of JC polyomaviruses from the cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy.

Authors:  Kazuo Nakamichi; Shuji Kishida; Kozue Tanaka; Akihiko Suganuma; Yasuteru Sano; Hironori Sano; Takashi Kanda; Norihisa Maeda; Jun-Ichi Kira; Ai Itoh; Natsuko Kato; Hidekazu Tomimoto; Ichiro Kurane; Chang-Kweng Lim; Hidehiro Mizusawa; Masayuki Saijo
Journal:  Arch Virol       Date:  2012-11-09       Impact factor: 2.574

3.  Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate.

Authors:  Rainer Gosert; Piotr Kardas; Eugene O Major; Hans H Hirsch
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

4.  Progressive Multifocal Leukoencephalopathy in Primary Immunodeficiencies.

Authors:  Jérôme Hadjadj; Aurélien Guffroy; Christophe Delavaud; Guillaume Taieb; Isabelle Meyts; Anne Fresard; Nathalie Streichenberger; Anne-Sophie L'Honneur; Flore Rozenberg; Maud D'Aveni; Claire Aguilar; Jérémie Rosain; Capucine Picard; Nizar Mahlaoui; Marc Lecuit; Olivier Hermine; Olivier Lortholary; Felipe Suarez
Journal:  J Clin Immunol       Date:  2018-12-14       Impact factor: 8.317

5.  Progressive multifocal leukoencephalopathy (PML) development is associated with mutations in JC virus capsid protein VP1 that change its receptor specificity.

Authors:  Leonid Gorelik; Carl Reid; Manuela Testa; Margot Brickelmaier; Simona Bossolasco; Annamaria Pazzi; Arabella Bestetti; Paul Carmillo; Ewa Wilson; Michele McAuliffe; Christopher Tonkin; John P Carulli; Alexey Lugovskoy; Adriano Lazzarin; Shamil Sunyaev; Kenneth Simon; Paola Cinque
Journal:  J Infect Dis       Date:  2011-07-01       Impact factor: 5.226

6.  Analysis of JC virus genotype distribution and transcriptional control region rearrangements in human immunodeficiency virus-positive progressive multifocal leukoencephalopathy patients with and without highly active antiretroviral treatment.

Authors:  Pasquale Ferrante; Serena Delbue; Elisabetta Pagani; Roberta Mancuso; Angela Marzocchetti; Elisa Borghi; Renato Maserati; Arabella Bestetti; Paola Cinque
Journal:  J Neurovirol       Date:  2003       Impact factor: 2.643

Review 7.  Intra-patient viral evolution in polyomavirus-related diseases.

Authors:  Dorian McIlroy; Franck Halary; Céline Bressollette-Bodin
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2019-05-27       Impact factor: 6.237

8.  HIV-associated progressive multifocal leukoencephalopathy: longitudinal study of JC virus non-coding control region rearrangements and host immunity.

Authors:  Marco Iannetta; Anna Bellizzi; Sara Lo Menzo; Elena Anzivino; Alessandra D'Abramo; Alessandra Oliva; Claudia D'Agostino; Gabriella d'Ettorre; Valeria Pietropaolo; Vincenzo Vullo; Maria Rosa Ciardi
Journal:  J Neurovirol       Date:  2013-05-29       Impact factor: 2.643

9.  Improving detection of JC virus by ultrafiltration of cerebrospinal fluid before polymerase chain reaction for the diagnosis of progressive multifocal leukoencephalopathy.

Authors:  Kazuo Nakamichi; Michi Kawamoto; Junko Ishii; Masayuki Saijo
Journal:  BMC Neurol       Date:  2019-10-25       Impact factor: 2.474

Review 10.  Progressive multifocal leukoencephalopathy and the spectrum of JC virus-related disease.

Authors:  Irene Cortese; Daniel S Reich; Avindra Nath
Journal:  Nat Rev Neurol       Date:  2020-11-20       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.